VJHemOnc is committed to improving our service to you

MDS 2020 | Anemia and transfusion dependence on QoL in MDS

VJHemOnc is committed to improving our service to you

Rena Buckstein

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses how anemia and transfusion dependence are independently prognostic of quality of life (QoL) in myelodysplastic syndromes (MDS), with reference to the EUMDS trial (NCT00600860). This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter